Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Bullboard Posts
Comment by thamthamon Sep 27, 2018 8:03am
40 Views
Post# 28699095

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Stock Options

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Stock Options
Rambo,

For your first question, I highly doubt it. Even if he wanted to, it will be years down the road. Gotta have serious investors with big money backing the company and very likely still need loans from banks. They gotta prove that they can generate solid revenue growth for at least the first few years and then they gotta persuade both investors and banks that they can continue to do so for years to come.

To take it private is pretty much shares buyback so they gotta name a price and have the approval of the shareholders in order to do so. No, the executives can't vote, only the rest. And the price gotta be reasonable enough that will secure a pass. In my company's case, the payout was double the SP at the time. One thing though, it goes by shares count and not shareholders count. So let's say minus the executives' shares, there's 50M shares owned by those who are able to vote. If one or two big shareholders owned over 25M and they vote yes, the rest are pretty much screwed.
Bullboard Posts